{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:15:18Z","timestamp":1795090518818,"version":"4.10.2"},"reference-count":62,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.8380","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T08:58:40Z","timestamp":1620291520000},"page":"e218380","source":"Crossref","is-referenced-by-count":40,"title":["Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018"],"prefix":"10.1001","volume":"4","author":[{"given":"Stine Munk","family":"Hald","sequence":"first","affiliation":[{"name":"Research Unit for Neurology, Odense University Hospital, Odense, Denmark"},{"name":"University of Southern Denmark, Odense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"Open Patient Data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark"},{"name":"Department of Clinical Research, University of Southern Denmark, Odense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Alberto","family":"Garc\u00eda Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Centro Espa\u00f1ol Investigaci\u00f3n Farmacoepidemiol\u00f3gica, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustam","family":"Al-Shahi Salman","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Hellfritzsch","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Hallas","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gaist","sequence":"additional","affiliation":[{"name":"Research Unit for Neurology, Odense University Hospital, Odense, Denmark"},{"name":"University of Southern Denmark, Odense"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,5,5]]},"reference":[{"issue":"6","key":"zoi210267r1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0b013e31829e6ffa","article-title":"Antithrombotic drugs and risk of hemorrhagic stroke in the general population.","volume":"81","author":"Garc\u00eda-Rodr\u00edguez","year":"2013","journal-title":"Neurology"},{"issue":"8","key":"zoi210267r2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202575","article-title":"Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study.","volume":"13","author":"Gulati","year":"2018","journal-title":"PLoS One"},{"issue":"9921","key":"zoi210267r3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"zoi210267r4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials.","volume":"119","author":"McQuaid","year":"2006","journal-title":"Am J Med"},{"issue":"7","key":"zoi210267r5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.amjmed.2014.01.031","article-title":"Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation.","volume":"127","author":"Larsen","year":"2014","journal-title":"Am J Med"},{"issue":"6","key":"zoi210267r6","first-page":"1290","article-title":"A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.","volume":"114","author":"Villines","year":"2015","journal-title":"Thromb Haemost"},{"key":"zoi210267r7","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.ijcard.2015.11.067","article-title":"\u2018Real-world\u2019 haemorrhagic rates for warfarin and dabigatran using population-level data in New Zealand.","volume":"203","author":"Nishtala","year":"2016","journal-title":"Int J Cardiol"},{"issue":"11","key":"zoi210267r8","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1001\/jamainternmed.2016.5954","article-title":"Stroke, bleeding, and mortality risks in elderly Medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation.","volume":"176","author":"Graham","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"6","key":"zoi210267r9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003725","article-title":"Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation.","volume":"5","author":"Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"zoi210267r10","doi-asserted-by":"publisher","first-page":"i3189","DOI":"10.1136\/bmj.i3189","article-title":"Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.","volume":"353","author":"Larsen","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"zoi210267r11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1160\/TH15-03-0247","article-title":"Dabigatran use in elderly patients with atrial fibrillation.","volume":"115","author":"Avgil-Tsadok","year":"2016","journal-title":"Thromb Haemost"},{"issue":"6","key":"zoi210267r12","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.chest.2016.07.013","article-title":"Direct comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in nonvalvular atrial fibrillation.","volume":"150","author":"Noseworthy","year":"2016","journal-title":"Chest"},{"issue":"10","key":"zoi210267r13","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1080\/03007995.2017.1334638","article-title":"Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients.","volume":"33","author":"Deitelzweig","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"zoi210267r14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1160\/TH17-01-0068","article-title":"Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in \u201creal-world\u201d clinical practice: a propensity-matched analysis of 76,940 patients.","volume":"117","author":"Li","year":"2017","journal-title":"Thromb Haemost"},{"issue":"1","key":"zoi210267r15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/ehjcvp\/pvw031","article-title":"A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.","volume":"3","author":"Halvorsen","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"6","key":"zoi210267r16","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jjcc.2016.08.010","article-title":"Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation.","volume":"69","author":"Bengtson","year":"2017","journal-title":"J Cardiol"},{"issue":"9","key":"zoi210267r17","first-page":"968","article-title":"Major bleeding risk during anticoagulation with warfarin, dabigatran, apixaban, or rivaroxaban in patients with nonvalvular atrial fibrillation.","volume":"23","author":"Adeboyeje","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"zoi210267r18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003418","article-title":"Sex-specific comparative effectiveness of oral anticoagulants in elderly patients with newly diagnosed atrial fibrillation.","volume":"10","author":"Palamaner Subash Shantha","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"zoi210267r19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191722","article-title":"Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: comparative effectiveness and safety evaluated using a propensity-score-matched approach.","volume":"13","author":"Li","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"zoi210267r20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008150","article-title":"Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in asians with nonvalvular atrial fibrillation.","volume":"7","author":"Chan","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"zoi210267r21","doi-asserted-by":"publisher","first-page":"k2505","DOI":"10.1136\/bmj.k2505","article-title":"Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.","volume":"362","author":"Vinogradova","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"zoi210267r22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/europace\/euw416","article-title":"Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study.","volume":"20","author":"Forslund","year":"2018","journal-title":"Europace"},{"key":"zoi210267r23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.thromres.2018.05.022","article-title":"Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation.","volume":"167","author":"Sj\u00e4lander","year":"2018","journal-title":"Thromb Res"},{"issue":"12","key":"zoi210267r24","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1161\/STROKEAHA.118.020232","article-title":"Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients.","volume":"49","author":"Lip","year":"2018","journal-title":"Stroke"},{"issue":"5","key":"zoi210267r25","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.amjmed.2018.12.023","article-title":"Comparative stroke, bleeding, and mortality risks in older Medicare patients treated with oral anticoagulants for nonvalvular atrial fibrillation.","volume":"132","author":"Graham","year":"2019","journal-title":"Am J Med"},{"issue":"6","key":"zoi210267r26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/ana.v85.6","article-title":"Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation.","volume":"85","author":"Seiffge","year":"2019","journal-title":"Ann Neurol"},{"key":"zoi210267r27","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.2099","article-title":"Clinical effectiveness of direct oral anticoagulants vs warfarin in older patients with atrial fibrillation and ischemic stroke: findings from the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study.","author":"Xian","year":"2019","journal-title":"JAMA Neurol"},{"issue":"7","key":"zoi210267r28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.7326\/M19-2522","article-title":"Effectiveness and safety of apixaban compared with rivaroxaban for patients with atrial fibrillation in routine practice: a cohort study.","volume":"172","author":"Fralick","year":"2020","journal-title":"Ann Intern Med"},{"issue":"11","key":"zoi210267r29","doi-asserted-by":"publisher","first-page":"897","DOI":"10.7326\/0003-4819-120-11-199406010-00001","article-title":"Risk factors for intracranial hemorrhage in outpatients taking warfarin.","volume":"120","author":"Hylek","year":"1994","journal-title":"Ann Intern Med"},{"issue":"7186","key":"zoi210267r30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/bmj.318.7186.759","article-title":"Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study.","volume":"318","author":"Thrift","year":"1999","journal-title":"BMJ"},{"issue":"10","key":"zoi210267r31","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.amjcard.2020.02.028","article-title":"Comparing major bleeding risk in outpatients with atrial fibrillation or flutter by oral anticoagulant type (from the National Cardiovascular Disease Registry\u2019s Practice Innovation and Clinical Excellence Registry).","volume":"125","author":"Wong","year":"2020","journal-title":"Am J Cardiol"},{"issue":"5","key":"zoi210267r32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jama.2017.21917","article-title":"Association of intracerebral hemorrhage among patients taking non-vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality.","volume":"319","author":"Inohara","year":"2018","journal-title":"JAMA"},{"issue":"23","key":"zoi210267r34","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1136\/heartjnl-2016-309402","article-title":"Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies.","volume":"102","author":"Adelborg","year":"2016","journal-title":"Heart"},{"issue":"9","key":"zoi210267r35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012023","article-title":"Changes in anticoagulant utilization among United States nursing home residents with atrial fibrillation from 2011 to 2016.","volume":"8","author":"Alcusky","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"zoi210267r36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12913-020-5058-1","article-title":"Trends in anticoagulant prescribing: a review of local policies in English primary care.","volume":"20","author":"Ho","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"zoi210267r37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1212\/WNL.0b013e31829e6eff","article-title":"Mortality after hemorrhagic stroke: data from general practice (The Health Improvement Network).","volume":"81","author":"Gonz\u00e1lez-P\u00e9rez","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"zoi210267r38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1474-4422(07)70107-2","article-title":"Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study.","volume":"6","author":"Lovelock","year":"2007","journal-title":"Lancet Neurol"},{"issue":"2","key":"zoi210267r39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1212\/01.wnl.0000250340.05202.8b","article-title":"The increasing incidence of anticoagulant-associated intracerebral hemorrhage.","volume":"68","author":"Flaherty","year":"2007","journal-title":"Neurology"},{"issue":"7","key":"zoi210267r40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1403494811399956","article-title":"Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving.","volume":"39","author":"Thygesen","year":"2011","journal-title":"Scand J Public Health"},{"key":"zoi210267r41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2147\/CLEP","article-title":"The Danish Stroke Registry.","volume":"8","author":"Johnsen","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"7","key":"zoi210267r42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System.","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"3","key":"zoi210267r44","first-page":"798","article-title":"Data resource profile: the Danish National Prescription Registry.","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"7","key":"zoi210267r46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register.","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"key":"zoi210267r48","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2147\/CLEP.S267583","article-title":"The validity of intracerebral hemorrhage diagnoses in the Danish Patient Registry and the Danish Stroke Registry.","volume":"12","author":"Hald","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"3","key":"zoi210267r49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies.","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"issue":"7","key":"zoi210267r50","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1161\/STROKEAHA.120.028825","article-title":"Comparative safety and effectiveness of oral anticoagulants in nonvalvular atrial fibrillation: The NAXOS Study.","volume":"51","author":"Van Ganse","year":"2020","journal-title":"Stroke"},{"issue":"23","key":"zoi210267r51","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1016\/j.jacc.2017.03.600","article-title":"Non-vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction.","volume":"69","author":"Yao","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"zoi210267r52","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation.","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"22","key":"zoi210267r53","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation.","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"zoi210267r54","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2020.1512","article-title":"Assessment of incidence and risk factors of intracerebral hemorrhage among participants in the Framingham Heart Study between 1948 and 2016.","author":"Lioutas","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"zoi210267r55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jash.2008.08.001","article-title":"Prevalence, awareness, and control of arterial hypertension in Denmark.","volume":"3","author":"Kronborg","year":"2009","journal-title":"J Am Soc Hypertens"},{"issue":"7138","key":"zoi210267r56","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(60)92299-6","article-title":"Anticoagulant drugs in the treatment of pulmonary embolism. a controlled trial.","volume":"1","author":"Barritt","year":"1960","journal-title":"Lancet"},{"issue":"12","key":"zoi210267r57","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"9678","key":"zoi210267r58","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"zoi210267r59","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1474-4422(09)70025-0","article-title":"Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.","volume":"8","author":"Feigin","year":"2009","journal-title":"Lancet Neurol"},{"issue":"2","key":"zoi210267r60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","article-title":"Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.","volume":"9","author":"van Asch","year":"2010","journal-title":"Lancet Neurol"},{"issue":"2","key":"zoi210267r61","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/pds.3391","article-title":"Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network.","volume":"22","author":"Gaist","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"zoi210267r62","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jama.2017.0639","article-title":"Association of antithrombotic drug use with subdural hematoma risk.","volume":"317","author":"Gaist","year":"2017","journal-title":"JAMA"},{"key":"zoi210267r43","author":"Rothman","year":"2008"},{"key":"zoi210267r33","unstructured":"United Nations. World Population Prospects: The 2020 Revision. Accessed October 11, 2020. https:\/\/www.un.org\/development\/desa\/pd\/news\/world-population-ageing-2020-highlights"},{"key":"zoi210267r45","unstructured":"medstat. Accessed November 15, 2020. https:\/\/medstat.dk\/en"},{"key":"zoi210267r47","unstructured":"Reference Program for Behandling af Patienter Med Apopleksi og TCI. 2013. Accessed January 1, 2021. http:\/\/www.dsfa.dk\/wp-content\/uploads\/REFERENCEPROGRAMFINAL20131.pdf?"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2779455\/hald_2021_oi_210267_1623352999.13306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T15:01:39Z","timestamp":1623942099000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2779455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,5]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.8380","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,5]]}}}